Author:
Hamid Sami,Muneer Asif,McNicholas Thomas A.
Publisher
Springer International Publishing
Reference15 articles.
1. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int. 2000;85(6):665–71.
2. Sturch P, Woo HH, McNicholas T, Muir G. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking? BJU Int. 2015;115(2):186–7.
3. McNicholas T, Speakman M, Kirby R. Evaluation and nonsurgical management of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia. In: Wein A, Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell – walsh urology, vol. 3. 11th ed. Philadelphia: Elsevier; 2016. p. 2463–503.
4. Braf Z, Chen J, Sofer M, Matzkin H. Intraprostatic metal stents (Prostakath and Urospiral): more than 6 years’ clinical experience with 110 patients. J Endourol. 1996;10(6):555–8.
5. Yachia D, Aridogan IA. Comparison between first-generation (fixed-caliber) and second-generation (self-expanding, large caliber) temporary prostatic stents. Urol Int. 1996;57(3):165–9.